These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39224912)
21. Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model. Guillaume P; Rupp T; Froget G; Goineau S Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273201 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue. Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465 [TBL] [Abstract][Full Text] [Related]
23. Topical application of a BCL-2 inhibitor ameliorates imiquimod-induced psoriasiform dermatitis by eliminating senescent cells. Zhu H; Jiang J; Yang M; Zhao M; He Z; Tang C; Song C; Zhao M; Akbar AN; Reddy V; Pan W; Li S; Tan Y; Wu H; Lu Q J Dermatol Sci; 2024 Aug; 115(2):54-63. PubMed ID: 38960840 [TBL] [Abstract][Full Text] [Related]
24. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis. Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695 [TBL] [Abstract][Full Text] [Related]
25. Evidence on the therapeutic role of thiolutin in imiquimod-induced psoriasis-like skin inflammation in mice. Wang A; Ma X; Wei F; Li Y; Liu Q; Zhang H Immun Inflamm Dis; 2023 Jul; 11(7):e877. PubMed ID: 37506136 [TBL] [Abstract][Full Text] [Related]
26. Artemisia monosperma essential oil nanoformulations alleviate imiquimod-induced psoriasis-like dermatitis in mice. Tawfik NF; Abdel-Rashid RS; El-Sayed EK; Abdel-Moneum R; Khattab MA; Ahmed AA; Lai KH; Hashad N; Moharram FA Int Immunopharmacol; 2024 Sep; 139():112733. PubMed ID: 39043105 [TBL] [Abstract][Full Text] [Related]
27. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
30. Liangxue Jiedu formula improves imiquimod-induced psoriasiform dermatitis with circadian desynchrony by regulating Th17 cell differentiation based on network pharmacological analysis. Xie X; Zhang L; Lin Y; Liu X; Han X; Li P J Ethnopharmacol; 2023 Dec; 317():116807. PubMed ID: 37331449 [TBL] [Abstract][Full Text] [Related]
31. Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes. Yen LJ; Chen YC; Wang KC; Shih MC; Li CL; Yu SJ; Lu LY Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):128-137. PubMed ID: 38059657 [TBL] [Abstract][Full Text] [Related]
32. Novel effect of topical Roquinimex and its combination with Clobetasol on an imiquimod-induced model of psoriasis in mice. Hasan AM; Gatea FK Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5219-5232. PubMed ID: 38265682 [TBL] [Abstract][Full Text] [Related]
33. The Development of Thermoresponsive Polymeric Simvastatin Prodrug for the Treatment of Experimental Periodontitis in Rats. Xu X; Jia Z; Chen N; Lele SM; Arash S; Reinhardt RA; Killeen AC; Wang D Mol Pharm; 2023 Nov; 20(11):5631-5645. PubMed ID: 37772991 [TBL] [Abstract][Full Text] [Related]
34. Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome. Evans EA; Sayers SR; Kodji X; Xia Y; Shaikh M; Rizvi A; Frame J; Brain SD; Philpott MP; Hannen RF; Caton PW Mol Metab; 2020 Nov; 41():101047. PubMed ID: 32599074 [TBL] [Abstract][Full Text] [Related]
35. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis. Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070 [TBL] [Abstract][Full Text] [Related]
36. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways. Sangaraju R; Alavala S; Nalban N; Jerald MK; Sistla R Int Immunopharmacol; 2021 Jul; 96():107754. PubMed ID: 34162135 [TBL] [Abstract][Full Text] [Related]
37. Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles. Sun L; Liu Z; Lin Z; Cun D; Tong HH; Yan R; Wang R; Zheng Y Int J Nanomedicine; 2018; 13():5625-5635. PubMed ID: 30271151 [TBL] [Abstract][Full Text] [Related]
38. Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice. Li L; Fu L; Zhou P; Lu Y; Zhang L; Wang W; Nie J; Zhang D; Liu Y; Wu B; Chen T Arch Dermatol Res; 2020 Sep; 312(7):481-490. PubMed ID: 31953572 [TBL] [Abstract][Full Text] [Related]
39. Suppression of neuropeptide by botulinum toxin improves imiquimod-induced psoriasis-like dermatitis via the regulation of neuroimmune system. Amalia SN; Uchiyama A; Baral H; Inoue Y; Yamazaki S; Fujiwara C; Sekiguchi A; Yokoyama Y; Ogino S; Torii R; Hosoi M; Ishikawa O; Motegi SI J Dermatol Sci; 2021 Jan; 101(1):58-68. PubMed ID: 33176965 [TBL] [Abstract][Full Text] [Related]
40. [Effect of fire needling on imiquimod induced psoriasis-like lesion and STAT3 pathway in mice]. Feng F; Wang Y; Zhao JX; Di TT; Meng YJ; Chen ZX; Qi C; Hu XQ; Wang YZ; Li P Zhongguo Zhen Jiu; 2022 May; 42(5):541-8. PubMed ID: 35543945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]